Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martha Skinner

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 12, 2010
Spontaneous rupture of the liver in a patient with systemic AL amyloidosis undergoing treatment with high-dose melphalan and autologous stem cell transplantation: a case report with literature reviewMartin Tam, David C Seldin, Benjamin M Forbes, et al.
Blood|September 9, 2006
Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trialVaishali Sanchorawala, Daniel G Wright, Michael Rosenzweig, et al.
Circulation|December 15, 2015
Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort StudyLawreen H Connors, Flora Sam, Martha Skinner, et al.
Analytical Chemistry|February 28, 2002
Characterization of transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysisAmareth Lim, Tatiana Prokaeva, Mark E McComb, et al.
Circulation Research|March 27, 2004
Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stressDaniel A Brenner, Mohit Jain, David R Pimentel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 31, 2012
Amyloid deposits in the bone marrow of patients with immunoglobulin light chain amyloidosis do not impact stem cell mobilization or engraftmentAndrew J Cowan, David C Seldin, Martha Skinner, et al.
Haematologica|June 27, 2012
Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experienceAndrew J Cowan, Martha Skinner, David C Seldin, et al.
Blood|August 24, 2006
Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65David C Seldin, Jennifer J Anderson, Martha Skinner, et al.
American Journal of Hematology|January 6, 2007
Association of acquired von Willebrand syndrome with AL amyloidosisCynthia A Kos, Jennifer E Ward, Karim Malek, et al.
British Journal of Haematology|June 13, 2002
Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosisVaishali Sanchorawala, Daniel G Wright, David C Seldin, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 12, 2010
Spontaneous rupture of the liver in a patient with systemic AL amyloidosis undergoing treatment with high-dose melphalan and autologous stem cell transplantation: a case report with literature reviewMartin Tam, David C Seldin, Benjamin M Forbes, et al.
Blood|September 9, 2006
Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trialVaishali Sanchorawala, Daniel G Wright, Michael Rosenzweig, et al.
Circulation|December 15, 2015
Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort StudyLawreen H Connors, Flora Sam, Martha Skinner, et al.
Analytical Chemistry|February 28, 2002
Characterization of transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysisAmareth Lim, Tatiana Prokaeva, Mark E McComb, et al.
Circulation Research|March 27, 2004
Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stressDaniel A Brenner, Mohit Jain, David R Pimentel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 31, 2012
Amyloid deposits in the bone marrow of patients with immunoglobulin light chain amyloidosis do not impact stem cell mobilization or engraftmentAndrew J Cowan, David C Seldin, Martha Skinner, et al.
Haematologica|June 27, 2012
Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experienceAndrew J Cowan, Martha Skinner, David C Seldin, et al.
Blood|August 24, 2006
Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65David C Seldin, Jennifer J Anderson, Martha Skinner, et al.
American Journal of Hematology|January 6, 2007
Association of acquired von Willebrand syndrome with AL amyloidosisCynthia A Kos, Jennifer E Ward, Karim Malek, et al.
British Journal of Haematology|June 13, 2002
Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosisVaishali Sanchorawala, Daniel G Wright, David C Seldin, et al.
Pageof 6